In a bold move into relatively uncharted waters, drug researchers are delving into the curative effects of the psychotropic drug 5-MeO-DMT (also called mebufotenin) and studying its potential as a ...

GH Research PLC (NASDAQ:GHRS), a clinical-stage biopharma company developing novel mebufotenin (5-MeO-DMT) therapies for Treatment-Resistant Depression (TRD) and one of the highest trading ...

5-MeO-DMT is a potent and fast-acting psychedelic, which is naturally produced by the Sonoran Desert toad as well as some species of plants. Its short duration –from 20 minutes to one hour– is giving ...

A study examining subjective experiences after intranasal application of 5-MeO-DMT found that its effects peak 8-15 minutes after application. Consciousness-altering effects typically ended after ...

A new study published in Molecular Psychiatry suggests that the fast-acting psychedelic compound 5-MeO-DMT can reduce anxiety-like behavior in stressed mice while altering the expression of genes ...

This article was featured in One Great Story, New York’s reading recommendation newsletter. Sign up here to get it nightly. Beckley Park, a country estate in Oxfordshire, lies at the end of a narrow ...

Toronto, Ontario--(Newsfile Corp. - April 29, 2021) - Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company") is pleased to announce that certain of Mindset's Family 4 ...

You can add the Sonoran Desert Toad to the current escalating body count of threatened species worldwide, as the amphibious creature’s psychoactive secretions continue to gain popularity with ...

When Johannes Reckweg arrived in the Netherlands in 2016 to work on his master’s program in neuropsychology, he didn’t expect to learn about a psychedelic compound commonly found in a toad that lives ...